ŠPINAR, Jindřich, Jiří VÍTOVEC and Lenka ŠPINAROVÁ. Inhibitory SGLT2 - glifloziny v léčbě kardiovaskulárních onemocnění (SGLT2 inhibitors - gliflozins in the treatment and cardiovascular diseases). Remedia. 2020, vol. 30, No 2, p. 119-124, 5 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Inhibitory SGLT2 - glifloziny v léčbě kardiovaskulárních onemocnění
Name in Czech Inhibitory SGLT2 - glifloziny v léčbě kardiovaskulárních onemocnění
Name (in English) SGLT2 inhibitors - gliflozins in the treatment and cardiovascular diseases
Authors ŠPINAR, Jindřich, Jiří VÍTOVEC and Lenka ŠPINAROVÁ.
Edition Remedia, 2020.
Other information
Original language Czech
Type of outcome Article in a journal
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords (in Czech) glifloziny; léčba; kardiovaskulární onemocnění
Keywords in English gliflosins; treatmen; cardiovascular diseases
Tags Reviewed
Changed by Changed by: prof. MUDr. Jindřich Špinar, CSc., učo 2685. Changed: 7/1/2021 15:02.
Abstract
Článek popisuje efekt SGLT2 inhibitorů na kardiovaskulární onemocnění.
Abstract (in English)
The article describes the effect of SGT2 inhibitors on cardiovascular diseases.
PrintDisplayed: 23/7/2024 18:29